Schoolboy, 11, fatally hit by train while on phone
A heartbreaking rail accident report reveals how an 11-year-old boy's mobile phone use contributed to a fatal level crossing incident, sparking urgent safety warnings.
Category : Search result: mobile pricing
Xi Jinping's phone spying joke with South Korean leader
Chinese President Xi Jinping made a surprising quip about mobile phone surveillance during talks with South Korean President Yoon Suk Yeol, creating an unexpected moment of tension and humour in high-level diplomacy.
Phone Snatching: Britain's Growing Street Crime Epidemic
A powerful cartoon commentary exposes the rising tide of phone thefts plaguing urban centres, capturing the vulnerability of pedestrians glued to their devices.
London Mist Photo Wins Best Mobile Photography Award
Discover how Guillaume Lavrut's spontaneous London snap, capturing a mysterious figure in the fog, became an award-winning mobile photography sensation and what it reveals about modern creativity.
2024's Best Android Flagships: The Definitive Ranking
Our comprehensive showdown reveals which 2024 Android flagships truly dominate the market. From camera prowess to battery endurance, discover which premium phones justify their price tags and which fall short.
O2 criticised by Ofcom for undermining pricing rules
Telecoms regulator Ofcom has slammed O2 for tactics that 'go against the spirit' of new consumer protection rules, raising concerns about industry compliance with pricing transparency reforms.
Virgin Media O2 & Starlink boost UK rural coverage
Groundbreaking satellite deal will bring reliable 4G and 5G to remote British communities, bridging the digital divide across the countryside.
UK Pharma Crisis: Patients Face Treatment Delays
A critical pricing dispute between the UK government and pharmaceutical companies threatens patient access to vital medicines, with industry leaders warning of treatment delays and reduced NHS access to new drugs.
GSK CEO warns UK drug pricing reforms threaten life sciences
Emma Walmsley warns Britain's life sciences industry faces 'existential threat' from proposed drug pricing reforms that could drive investment and research overseas.
Page 1 of 1